{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:26Z","timestamp":1783075946058,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T00:00:00Z","timestamp":1237852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00228-009-0640-9","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T04:20:50Z","timestamp":1237782050000},"page":"795-801","source":"Crossref","is-referenced-by-count":19,"title":["O-demethylation of codeine to morphine inhibited by low-dose levomepromazine"],"prefix":"10.1007","volume":"65","author":[{"given":"M.","family":"Vevelstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tallaksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Br\u00f8rs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,24]]},"reference":[{"key":"640_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00280101","volume":"41","author":"J Desmeules","year":"1991","unstructured":"Desmeules J, Gascon MP, Dayer P, Magistris M (1991) Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol 41:23\u201326","journal-title":"Eur J Clin Pharmacol"},{"key":"640_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-199512000-00001","volume":"5","author":"SH Sindrup","year":"1995","unstructured":"Sindrup SH, Brosen K (1995) The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 5:335\u2013346","journal-title":"Pharmacogenetics"},{"key":"640_CR3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/cpt196674436","volume":"7","author":"WT Beaver","year":"1966","unstructured":"Beaver WT, Wallenstein SL, Houde RW, Rogers A (1966) A comparison of the analgesic effects of methotrimeprazine and morphine in patients with cancer. Clin Pharmacol Ther 7:436\u2013446","journal-title":"Clin Pharmacol Ther"},{"key":"640_CR4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.1961.03040480017004","volume":"178","author":"L Lasagna","year":"1961","unstructured":"Lasagna L, Dekornfeld TJ (1961) Methotrimeprazine: a new phenothiazine derivative with analgesic properties. JAMA 178:887\u2013890","journal-title":"JAMA"},{"key":"640_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03188779","volume":"17","author":"P Dayer","year":"1992","unstructured":"Dayer P, Desmeules J, Striberni R (1992) In vitro forecasting of drugs that may interfere with codeine bioactivation. Eur J Drug Metab Pharmacokinet 17:115\u2013120","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"640_CR6","first-page":"89","volume":"22","author":"EK Syvalahti","year":"1986","unstructured":"Syvalahti EK, Lindberg R, Kallio J, De Vocht M (1986) Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br J Clin Pharmacol 22:89\u201392","journal-title":"Br J Clin Pharmacol"},{"key":"640_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00007691-199302000-00003","volume":"15","author":"LF Gram","year":"1993","unstructured":"Gram LF, Hansen MG, Sindrup SH, Brosen K, Poulsen JH, Aaes-Jorgensen T, Overo KF (1993) Citalopram: interaction studies with levomepromazine, imipramine, and lithium. Ther Drug Monit 15:18\u201324","journal-title":"Ther Drug Monit"},{"key":"640_CR8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2125.1990.tb03827.x","volume":"30","author":"J Kallio","year":"1990","unstructured":"Kallio J, Huupponen R, Seppala M, Sako E, Iisalo E (1990) The effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine. Br J Clin Pharmacol 30:638\u2013643","journal-title":"Br J Clin Pharmacol"},{"key":"640_CR9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0447.1992.tb03281.x","volume":"86","author":"E Spina","year":"1992","unstructured":"Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP (1992) Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions. Acta Psychiatr Scand 86:364\u2013366","journal-title":"Acta Psychiatr Scand"},{"key":"640_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","volume":"71","author":"DW Boulton","year":"2002","unstructured":"Boulton DW, DeVane CL, Liston HL, Markowitz JS (2002) In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci 71:163\u2013169","journal-title":"Life Sci"},{"key":"640_CR11","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","volume":"96","author":"HE Hassan","year":"2007","unstructured":"Hassan HE, Myers AL, Lee IJ, Coop A, Eddington ND (2007) Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel\u2019s tissue distribution in Sprague Dawley rats. J Pharm Sci 96:2494\u20132506","journal-title":"J Pharm Sci"},{"key":"640_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007691-199710000-00010","volume":"19","author":"QY Yue","year":"1997","unstructured":"Yue QY, Alm C, Svensson JO, Sawe J (1997) Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators. Ther Drug Monit 19:539\u2013542","journal-title":"Ther Drug Monit"},{"key":"640_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/bdd.2510130607","volume":"13","author":"TB Vree","year":"1992","unstructured":"Vree TB, Verwey-van Wissen CP (1992) Pharmacokinetics and metabolism of codeine in humans. Biopharm Drug Dispos 13:445\u2013460","journal-title":"Biopharm Drug Dispos"},{"key":"640_CR14","first-page":"251","volume":"114","author":"TK Adler","year":"1955","unstructured":"Adler TK, Fujimoto JM, Way EL, Baker EM (1955) The metabolic fate of codeine in man. J Pharmacol Exp Ther 114:251\u2013262","journal-title":"J Pharmacol Exp Ther"},{"key":"640_CR15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","volume":"27","author":"JG Shin","year":"1999","unstructured":"Shin JG, Soukhova N, Flockhart DA (1999) Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. Drug Metab Dispos 27:1078\u20131084","journal-title":"Drug Metab Dispos"},{"key":"640_CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.1991.77","volume":"49","author":"K Brosen","year":"1991","unstructured":"Brosen K, Zeugin T, Meyer UA (1991) Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clin Pharmacol Ther 49:609\u2013617","journal-title":"Clin Pharmacol Ther"},{"key":"640_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0773.1994.tb00357.x","volume":"75","author":"PA Hals","year":"1994","unstructured":"Hals PA, Dahl SG (1994) Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat. Pharmacol Toxicol 75:255\u2013260","journal-title":"Pharmacol Toxicol"},{"key":"640_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007691-199706000-00003","volume":"19","author":"A Suzuki","year":"1997","unstructured":"Suzuki A, Otani K, Ishida M, Yasui N, Kondo T, Mihara K, Kaneko S, Inoue Y, Shibata M, Ikeda K (1997) Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine. Ther Drug Monit 19:261\u2013264","journal-title":"Ther Drug Monit"},{"key":"640_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199300810-00010","volume":"8","author":"A Grinshpoon","year":"1993","unstructured":"Grinshpoon A, Berg Y, Mozes T, Mester R, Weizman A (1993) Seizures induced by combined levomepromazine-fluvoxamine treatment. Int Clin Psychopharmacol 8:61\u201362","journal-title":"Int Clin Psychopharmacol"},{"key":"640_CR20","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1373\/clinchem.2003.030825","volume":"50","author":"W Steimer","year":"2004","unstructured":"Steimer W, Zopf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, Messner B, Kissling W, Leucht S (2004) Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers. Clin Chem 50:1623\u20131633","journal-title":"Clin Chem"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0640-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-009-0640-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0640-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T16:36:23Z","timestamp":1739032583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-009-0640-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,24]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s00228-009-0640-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,24]]}}}